{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:09:21Z","timestamp":1794535761270,"version":"4.9.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.neurot.2024.e00382","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T19:32:31Z","timestamp":1718220751000},"page":"e00382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Baseline neurological deficit and argatroban plus alteplase in acute ischemic stroke: A post hoc analysis of ARAIS trial"],"prefix":"10.1016","volume":"21","author":[{"given":"Yu","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-He","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.neurot.2024.e00382_bib1","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00382_bib2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.STR.0000258112.14918.24","article-title":"The impact of recanalization on ischemic stroke outcome: a meta-analysis","volume":"38","author":"Rha","year":"2007","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00382_bib3","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1212\/WNL.59.6.862","article-title":"Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator","volume":"59","author":"Alexandrov","year":"2002","journal-title":"Neurology"},{"issue":"10029","key":"10.1016\/j.neurot.2024.e00382_bib4","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00382_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.STR.0000251800.01964.f6","article-title":"Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study","volume":"38","author":"Saqqur","year":"2007","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00382_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1080\/01616412.2018.1495882","article-title":"Argatroban plus aspirin versus aspirin in acute ischemic stroke","volume":"40","author":"Chen","year":"2018","journal-title":"Neurol Res"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00382_bib7","first-page":"605","article-title":"Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke","volume":"254","author":"Hosomi","year":"2007","journal-title":"J\u00a0Neurol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00382_bib8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/STROKEAHA.111.625574","article-title":"The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety study","volume":"43","author":"Barreto","year":"2012","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00382_bib9","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/STROKEAHA.117.016720","article-title":"Randomized, multicenter trial of ARTSS-2 (argatroban with recombinant tissue plasminogen activator for acute stroke)","volume":"48","author":"Barreto","year":"2017","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00382_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1001\/jama.2023.0550","article-title":"Effect of argatroban plus intravenous alteplase vs intravenous alteplase alone on neurologic function in patients with acute ischemic stroke: the ARAIS randomized clinical trial","volume":"329","author":"Chen","year":"2023","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00382_bib11","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1161\/01.STR.0000182099.04994.fc","article-title":"NIHSS score and arteriographic findings in acute ischemic stroke","volume":"36","author":"Fischer","year":"2005","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00382_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10072-018-3644-3","article-title":"Management of acute ischemic stroke, thrombolysis rate, and predictors of clinical outcome","volume":"40","author":"Bandettini di Poggio","year":"2019","journal-title":"Neurol Sci"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00382_bib13","first-page":"340","article-title":"Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction","volume":"254","author":"Tei","year":"2007","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.neurot.2024.e00382_bib14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ahj.2020.04.003","article-title":"Randomized trial of argatroban plus recombinant tissue-type plasminogen activator for acute ischemic stroke (ARAIS): rationale and design","volume":"225","author":"Yang","year":"2020","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00382_bib15","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/01.STR.0000016323.13456.E5","article-title":"Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion","volume":"33","author":"Molina","year":"2002","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00382_bib16","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1161\/01.STR.0000027861.75884.DF","article-title":"Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke","volume":"33","author":"Arenillas","year":"2002","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00382_bib17","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00382_bib18","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1161\/STROKEAHA.114.005135","article-title":"Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials","volume":"45","author":"Rao","year":"2014","journal-title":"Stroke"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00382_bib19","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.STR.30.11.2280","article-title":"Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort","volume":"30","author":"Fiorelli","year":"1999","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00382_bib20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.003","article-title":"Large vessel occlusion score: a screening tool to detect large vessel occlusion in the acute stroke setting","volume":"28","author":"V Martins-Filho","year":"2019","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00382_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12883-022-02737-8","volume":"22","author":"Che","year":"2022","journal-title":"BMC Neurol"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00382_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2664","article-title":"Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis","volume":"12","author":"Li","year":"2022","journal-title":"Brain Behav"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:11:09Z","timestamp":1762560669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924000680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1878747924000680"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00382","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline neurological deficit and argatroban plus alteplase in acute ischemic stroke: A post hoc analysis of ARAIS trial","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00382","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00382"}}